nuklearmedizin - nuclearmedicine
130620
DE
EN
Home
Products
Journals
Books
Book Series
Service
Library Service
Help
Contact
Portal
Nuklearmedizin - NuclearMedicine
Full-text search
Full-text search
Author Search
Title Search
DOI Search
Metadata Search
Journal
About this journal
Editorial Board
Impact Factor
Imprint
Job Board
Media
Authors
Instructions for authors
Subscription
Subscription Information
Institutional Licensing
Affiliated Societies
Deutsche Gesellschaft für Nuklearmedizin (DGN)
Österreichische Gesellschaft für Nuklearmedizin und Molekulare Bildgebung (OGNMB)
Schweizerische Gesellschaft für Nuklearmedizin (SGNM/SSNM)
PharmaMarket
PharmaMarket
Not Logged In
Login
Username or e-mail address:
Password:
Forgot Access Data?
Register Now
OpenAthens/Shibboleth Login
Shopping Cart
Year (Archive)
2024
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1989
1988
1987
1986
1985
1984
1983
1982
1981
1980
1979
1978
1977
1976
1975
1974
1973
1972
1971
1970
1969
1968
1967
1965
1964
1963
1962
1961
Issues
Current Issue
Free Sample Issue (01/2024)
Abstracts (HTML)
List of Authors
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Ö
Jabulowsky, R
Imaging Immune activation by FDG PET/CT after systemic cancer vaccination therapy
Jäger, D
Ga-68-FAPI PET/CT: Ein Überblick zum Tracer-Uptake bei 28 unterschiedlichen Tumorentitäten
Jain, R
The T2-FLAIR mismatch sign in IDH-mutant astrocytomas - Is there an association with FET PET uptake?
Jakoby, B
MRT-basierte Bewegungskorrektur von hypermetabolen Lungenläsionen: Vergleich quantitativer PET-Daten unterschiedlicher Rekonstruktionsprogramme
Jakucinski, M
Targeted alpha therapy of recurrent glia tumors: clinical experience with
225
Ac-Substance-P
Jallapally, A
Development of FAP-inhibitors based on squaric acid linked DOTA and DATA5m chelators
Jann, H
Progressionsfreies Überleben und Nebenwirkungsprofil für die Lu-177-DOTATOC PRRT bei GEP-NET: Abhängigkeit von Alter und Geschlecht
Janssen, M
Lutetium-177-PSMA-617 in low-volume hormone sensitive metastatic prostate cancer: a prospective study
Jaschinski, M
Structure-affinity relationships of estrogen derivatives to ERα as precursors for radiolabeling in endoradiotherapy of breast cancer
Jellinek, A
Clinical impact of follicular oncocytic (Hürthle cell) carcinoma in comparison to corresponding classical follicular thyroid carcinoma
Jentzen, W
Emission time optimisation for Ga-68-PSMA with a digital PET/CT – a phantom study
Assessment of the prompt gamma coincidence correction approach using I-124: a phantom study
Evaluation of tissue-dependent and spatially-variant positron-range correction for Iodine-124 PET/MR data
Quantitative SPECT/CT zur Diagnostik von kardialer Amyloidose – Methodik und erste Daten
Reducing emission time in prostate cancer patients undergoing Ga-68-PSMA PET/CTon a digital system
Digital PET/CT improves the minimal detectable I-124 activity and dosimetry for small iodine-avid thyroid cancer metastases
Jessen, F
Amyloid-related changes of basal forebrain volume and precuneus functional connectivity in Subjective Cognitive Decline patients
Jevtić, II
Development of fluorinated indanone-based derivatives for the imaging of monoamine oxidase B via positron emission tomography
Jilg, CA
Voxel-weiser Vergleich der Ga-68-RM2-PET mit der Histologie und mit der Ga-68-HBED-CC-PET zur besseren Bestimmung der lokalen Tumorausdehnung beim primären Prostatakarzinom
Jochimsen, T
Einfluss künstlicher Intelligenz auf beta-Amyloid(Aß)-PET/MRT-Untersuchungen
Evaluierung neuartiger Verfahren zur Bewegungskorrektur in der simultanen PET/MRT
Joksch, M
Assessment of the efficacy of targeted PDA-66 therapy in a PC-3 Prostate Cancer Xenograft Model using [
18
F]FDG and [
18
F]FLT PET/CT and MRI
Jones, J
Clinical evaluation of a data-driven gating algorithm for whole-body PET/CT scans in continuous bed mode
Jonnalagadda, S
Novel 2-fluoropyridinyl analogs of FACH and biological evaluation of one potential radioligand for imaging of monocarboxylate transporters (MCTs) with PET
Jonnalagadda, SK
Novel 2-fluoropyridinyl analogs of FACH and biological evaluation of one potential radioligand for imaging of monocarboxylate transporters (MCTs) with PET
Jost, WH
Differentialdiagnostik des Parkinson-Syndroms: Ein Vergleich von FDG-PET und MIBG-Szintigraphie
Jouanjan, LA
FDG-PET bei Lungenkrebs; kann uns die Texturanalyse helfen, malignes Gewebe besser abzugrenzen?
Junghanß, C
Assessment of the efficacy of targeted PDA-66 therapy in a PC-3 Prostate Cancer Xenograft Model using [
18
F]FDG and [
18
F]FLT PET/CT and MRI